CNH and HD Hyundai announce joint innovation program for the construction sector at CES 12-01-2024, 03:00

MoonLake Immunotherapeutics announces the full dataset from its 24-week MIRA clinical trial, establishing the Nanobody® sonelokimab as a highly promising and differentiated therapeutic solution for Hidradenitis Suppurativa 15-10-2023, 20:03

VoltaGrid Closes $5.0 Billion Comprehensive Financing Package Consisting of $2.0 Billion of Senior Secured Second Lien Notes and $3.0 Billion Asset-Based Loan Facility 10-11-2025, 20:00